Sonora Investment Management’s VanEck Biotech ETF BBH Stock Holding History

Sonora Investment Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$10K	Hold	48	–	–	﹤0.01%	771
2021 Q2	$10K	Buy	+48	New	+$8.94K	﹤0.01%	705
2021 Q1	–	Sell	-15	Closed	-$3K	–	1734
2020 Q4	$3K	Hold	15	–	–	﹤0.01%	1546
2020 Q3	$2K	Hold	15	–	–	﹤0.01%	1619
2020 Q2	$2K	Hold	15	–	–	﹤0.01%	1560
2020 Q1	$2K	Buy	+15	New	+$2.02K	﹤0.01%	1463

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Sonora Investment Management's BBH Position: Q3 2021 in Review

Sonora Investment Management held its VanEck Biotech ETF (BBH) position steady in Q3 2021 at 48 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Sonora Investment Management first reported a position in BBH in Q1 2020 and has held it in 6 quarters since. 118 funds tracked by Wall St. Rank hold BBH as of Q3 2021.

Sonora Investment Management held 48 shares of VanEck Biotech ETF worth $10K as of Q3 2021.
Sonora Investment Management left its VanEck Biotech ETF share count unchanged in Q3 2021.
VanEck Biotech ETF made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #771 holding.
Sonora Investment Management first reported a position in VanEck Biotech ETF in Q1 2020 and has held it in 6 quarters since.
118 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.